OAC
CAMP icon

OMERS Administration Corp’s CAMP4 Therapeutics CAMP Stock Holding History

OMERS Administration Corp’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,800
Closed -$115K – 1110
2025
Q4 		$115K Buy
+18,800
New +$80K ﹤0.01% 962

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

OMERS Administration Corp's CAMP Position: Q1 2026 in Review

OMERS Administration Corp sold out of CAMP4 Therapeutics (CAMP) in Q1 2026, closing a stake of 18,800 shares — an estimated $115K sold.

OMERS Administration Corp first reported a position in CAMP in Q4 2025 and held it in 1 quarter. The position peaked at $115K in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • OMERS Administration Corp reported no remaining CAMP4 Therapeutics position as of Q1 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 18,800 CAMP4 Therapeutics shares in Q1 2026, an estimated $115K.
  • OMERS Administration Corp first reported a position in CAMP4 Therapeutics in Q4 2025 and held it in 1 quarter.
  • OMERS Administration Corp's CAMP4 Therapeutics position peaked at $115K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.